Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Potent and selective PDE7 inhibitors discovered at Celltech

Feb. 6, 2002

AtheroGenics identifies inhibitors of VCAM-1 expression

Feb. 6, 2002

AstraZeneca claims compounds which modulate chemokine receptors

Feb. 6, 2002

Efalizumab to be evaluated in rheumatoid arthritis

Feb. 6, 2002

Preparation and use of pipecolic acid derivatives with MMP-inhibitory activity

Feb. 5, 2002

Chronic inflammation, bone damage attenuated by M-40403 in rat model of arthritis

Feb. 4, 2002

Toyama discloses novel benzophenone derivatives for use in arthritis in recent patent

Jan. 31, 2002

Antiinflammatory effects demonstrated for adenosine uptake inhibitor in LPS-treated mice

Jan. 31, 2002

5G1.1 enters phase IIb trial in rheumatoid arthritis

Jan. 31, 2002

Adamantane-based P2X7 receptor antagonists discovered by AstraZeneca team

Jan. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...